Transgender health: Hormone therapy may raise risk of CV events
This week from MDedge Cardiology, a biodegradable polymer shows no long-term benefit in heart stents, appropriate use criteria for imaging in nonvalvular heart disease are released, ACOG updates guidance on hypertension in pregnancy, and more losartan lots are recalled.
Subscribe to Cardiocast wherever you get your podcasts.
Amazon AlexaApple Podcasts
We noticed you have an ad blocker enabled. Please whitelist us so we can continue to provide free content.